Contact PI/Project LeaderSARIOL, CARLOS A Other PIs
Awardee OrganizationUNIVERSITY OF PUERTO RICO MED SCIENCES
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT:
The primary goal of this application is to sustain the Specific Pathogen Free (SPF) program at the Caribbean
Primate Research Center (CPRC) through the support of operations, administration, veterinary care, virological
and MHC typing, and by the improvement of our comprehensive genetic management plan. Animals'
characterization, both for the virology profile and MHC typing, is performed by state-of-the-art methodologies.
A unique feature of CPRC animals in favoring a successful establishment and sustainability of SPF colony is that
these animals are naturally free of SIV and SRV-D, two of the four viruses to be tested. Nevertheless, we continue
systematically testing for all four viruses (B virus, STLV, SIV, and SRV-D) for safety and as required for the SPF
Program. The Program provides unadmixed Indian-origin rhesus monkeys with a defined genetic and virological
background. The population genetic analyses revealed that the SPF colony has remained genetically homogenous
over time with sufficient heterozygosity and minimal stratification from its non-SPF founders. Genetic variation
will be maintained in the SPF colony using the genetic management strategies described in this application. The
genetic management approach will allow for the enrichment of desired MHC markers in demand for biomedical
research while maintaining genetic diversity. Our genetic management approach will be concordant with the
NIH's National NHP Genetics and Genomics Consortium guidelines for ensuring the long-term viability of the
CPRC's SPF colony. The estimates of Indian ancestry among the SSFS SPF colony animals are also among the
highest that has been calculated across several National Primate Research Centers in the US. Funds are requested
in this application to sustain the SPF program and to meet the proposed aims. With continued NIH support,
Institutional contribution, and funds from the program income, the SPF program at CPRC will remain a
significant national research resource. They will be able to provide healthy SPF Indian-origin rhesus monkeys of
defined genetic and virological background to NIH-sponsored research programs. The Covid-19 pandemic poses
high pressure on the demand for rhesus macaques. The U42 at CPRC supported the development of some of the
Covid-19 vaccine formulations in the market. Currently, the demand continues to exceed the SPF animal's
availability. However, our Program has supported several investigators conducting cutting-edge research on HIV
and AIDS-related research projects in various areas, including pathobiology, characterization of the immune
response, con-infections, and comorbidities, development of new HIV/AIDS vaccines and therapeutic
approaches, including microbicides, among others.
Public Health Relevance Statement
NARRATIVE:
The primary goal of this application is to sustain the Specific Pathogen Free (SPF) program at the Caribbean
Primate Research Center (CPRC). Animals' characterization, both for the virology profile and MHC typing, is
performed by state-of-the-art methodologies. The program supports several investigators conducting cutting-
edge research on HIV and AIDS-related research projects in various areas, including pathobiology,
characterization of the immune response, con-infections, and comorbidities, development of new HIV/AIDS
vaccines and therapeutic approaches, including microbicides, among others.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Acquired Immunodeficiency SyndromeAlgorithmsAnimalsAreaBiologicalBiological ModelsBiological WarfareBiomedical ResearchBreedingBudgetsCOVID-19 pandemicCOVID-19 vaccineCaribbean regionCaringCharacteristicsCollaborationsCommunicable DiseasesCommunitiesDevelopmentDiseaseEducationEnsureEtiologyFundingGeneticGenetic VariationGenomicsGeographic LocationsGoalsGuidelinesHIV vaccineHIV/AIDSHeterozygoteHumanImmune responseIncomeIndiaInfectionInstitutionInterventionIslandJournalsMacaca mulattaMaintenanceMajor Histocompatibility ComplexMarketingMedicalMedicineMethodologyMethodsModelingMonkeysNaturePopulationPopulation GeneticsPrimatesPublicationsPuerto RicoResearchResearch PersonnelResearch Project GrantsResourcesRetroviridaeSARS-CoV-2 pathogenesisSIVSafetyScienceSecureSimian RetrovirusesStratificationTestingTherapeuticTimeTrainingUnited States National Institutes of HealthUnited States Public Health ServiceUniversitiesVaccine TherapyViralVirusWorkbiodefenseco-infectioncohortcomorbiditycomparativedriving forcegene therapygenetic analysisgerm free conditionhuman diseaseimprovedmicrobicidenonhuman primateoffspringoperationpeerpressureprogramsresearch and developmenttherapeutic developmentvaccine developmentvaccine formulationvirologyvirus testing
No Sub Projects information available for 2U42OD021458-23
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2U42OD021458-23
Patents
No Patents information available for 2U42OD021458-23
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2U42OD021458-23
Clinical Studies
No Clinical Studies information available for 2U42OD021458-23
News and More
Related News Releases
No news release information available for 2U42OD021458-23
History
No Historical information available for 2U42OD021458-23
Similar Projects
No Similar Projects information available for 2U42OD021458-23